Replies to post #286896 on NorthWest Biotherapeutics Inc (NWBO)

[photonic5]

Diver

I do appreciate the transparency, but management has let down investors repeatedly with guidelines on this trial conclusion. First it was “pedal to the metal”. Then it was...”we have completed most of the queries” last June. Next it was... “finalizing the SAP took longer than expected”. Then...”COVID has disrupted finalizing the data collection process, but we expect end of May datalock. Now...”well, it might be end of June now”

What’s next? I was with alphapuppy at ASCO last year when Dave Innes was saying that he’d bet a steak that we’d have topline data by last October. Chris L was there too. He finally bailed. Too many lies.

You can only buy these lines for so long before credibility is damaged beyond repair. Management has done themselves no favors here.

[Sharkee2]

The real problem is that they cannot plan or keep us updated about the plan.

The real problem is that they cannot anticipate risks when nothing has changed from mid Apr to now.

The real problem is that they have regressed from data lock to soft data lock throwing into ditch the TLD timelines completely.

The real problem is folks like you who keep pushing the narrative that when someone asks a question about management who make several hundred thousands a year, that they are a bear and will somehow make the trial fail.